<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Biontech Q3-regnskab. Nu 13,4 mia € i kassen]]></title><description><![CDATA[<p dir="auto">Vaccine-vinderen fortsætter med at tjene penge. I langsommere tempo end sidste år. <a href="https://investors.biontech.de/news-releases/news-release-details/biontech-announces-third-quarter-2022-financial-results-and" rel="nofollow ugc">https://investors.biontech.de/news-releases/news-release-details/biontech-announces-third-quarter-2022-financial-results-and</a></p>
<p dir="auto">De har nu 13,4 mia € i kassen. Det skal sammenholdes med en markedsværdi på 37,45 mia $ (kurs 154). Dvs. mere en tredjedel af aktiernes værdi er til stede i form af kontanter.</p>
<p dir="auto">Hertil kommer dels indtægter fra fortsat salg af vaccine. Bemærk, at Ugur Sahin lige har været med Scholz i Kina.</p>
<p dir="auto">Dels værdien af en pipeline, som jeg ikke kan bedømme.</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/444452/biontech-q3-regnskab-nu-134-mia-i-kassen</link><generator>RSS for Node</generator><lastBuildDate>Sun, 28 Jun 2026 12:34:12 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/444452.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 07 Nov 2022 10:49:25 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Biontech Q3-regnskab. Nu 13,4 mia € i kassen on Mon, 07 Nov 2022 11:43:34 GMT]]></title><description><![CDATA[<p dir="auto">BioNTech Q3 Profit Down; Lifts FY22 COVID-19 Vaccine Revenue View</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.proinvestor.com/investornyt/901056/biontech-q3-profit-down-lifts-fy22-covid-19-vaccine-revenue-view">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.proinvestor.com/investornyt/901056/biontech-q3-profit-down-lifts-fy22-covid-19-vaccine-revenue-view" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.proinvestor.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.proinvestor.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9478551</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9478551</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 07 Nov 2022 11:43:34 GMT</pubDate></item></channel></rss>